ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TransNusa Signs Agreement with Three Renowned Medical Centres in Malaysia



JAKARTA, Oct 23, 2024 - (ACN Newswire) - Realising yet another milestone, TransNusa has signed agreements with Sunway Medical Centre and Asia OneHealthCare with the aim to provide its passengers with additional healthcare options and thus, expanding its operations into the Medical Tourism Industry.

TransNusa recently inked agreements with three medical centres allowing its passengers to enjoy additional privileges in the medical centres. The medical centres are Sunway Medical Centre, Subang Jaya Medical Centre and Ara Damansara Medical Centre. Subang Jaya Medical Centre and Ara Damansara Medical Centre are owned by Asia OneHealthCare.

TransNusa Group Chief Executive Officer, Datuk Bernard Francis said, “We feel privileged to be able to expand our service offerings to include healthcare. Our Passengers will be eligible to purchase specialised and customised healthcare packages at three renowned medical centres in Malaysia.

“TransNusa’ passengers can now enjoy two Signature Elite Health Screening Package, which is valued at RM1500 (USD348) at RM750 (Estimated USD174) at Sunway Medical Centre. The package price is being offered at a 50 per cent discount for TransNusa’ passenger. In addition to the discount, passengers will be able to enjoy free seat upgrades.  

“In order to be eligible for the above package, our passengers will need to showcase their boarding passes when registering for the package at Sunway Medical Centre,” explained Datuk Francis.

“Passengers who fly TransNusa will also be able to enjoy a 20 per cent discount for all medical check-up at Subang Jaya Medical Centre and Ara Damansara Medical Centre,” Datuk Francis continued, adding that passengers will also be able to enjoy free airport transfer from the Subang Airport to the Subang Jaya Medical Centre and Ara Damansara Medical Centre.

LEADING TRANSNUSA TO GREATER HEIGHTS... Datuk Bernard Francis, Chief Executive Officer, TransNusa

All three medical centres are close to Subang Airport, with Ara Damansara Medical Centre being the closest. The medical centre is only 7.9km from the Subang Airport, which is also known as the Sultan Abdul Aziz Shah Airport. Meanwhile, Sunway Medical Centre is 14 km from the airport and Subang Jaya Medical Centre is 13km from the airport.

TransNusa will be operating one daily scheduled flight from Terminal 3, Soekarno-Hatta International Airport to Subang Airport. The flight, 8B 699, will depart Jakarta at 04.10pm and arrive at the Subang Airport at 07.00pm while TransNusa flight, 8B 698, will depart Subang Airport at 07.30pm and arrive in Jakarta at 08.30pm. TransNusa will be utilizing its A320 narrow-body airliner, which has 174 seats, to cater for the two-hour scheduled flight. TransNusa ticket for this route is competitively priced from RM240 (Estimated USD54).

TransNusa, which had to close it business operation in September 2020 due to impact of the Covid-19 pandemic on the aviation industry, started operations again after injection of new shareholders and management team led by Malaysian-born aviation industry veteran, Datuk Bernard Francis, in October 2022.

Within 6 months, under the leadership of Datuk Francis, the airline introduced its first international route between Jakarta and Kuala Lumpur and celebrated its first-year anniversary for this route on April 14, 2024.

Since the change in management team, TransNusa has been contributing and changing the aviation landscape in Indonesia. It has been making headlines in Indonesia, Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided its passengers with more pricing and route options to China. In addition, the airline also became the first airline outside China to utilise the COMAC ARJ21-700.

Primary Media Contact
Trina Thomas Raj
+6012 499 2672
trina@myqaseh.org

About TransNusa

TransNusa Airline is a Premium Service Carrier. After the take-over in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.

TransNusa, which received its AOC certification on 9th September 2022, launched its first three A320 operations on 6th October, 14th October and 12th December, 2022. The airline, which became the first outside of China to utilise Comac, received its first ARJ21 on 22nd December, 2022.  In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta Soekarno-Hatta International Airport.

The airline currently flies to Yogyakarta and Bali. On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur and Johor. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.

Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at +6221 631 0888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd on +65 8660 2719, while for the Malaysian market passengers can contact MKM Ticketing Travel & Tours Sdn Bhd on +6037 831 2581.

]]>

Source: TransNusa

Copyright 2024 ACN Newswire . All rights reserved.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.